The influence of gut microbiota on the progression of Type 2 Diabetes

a new perspective for treatment and prevention

Authors

  • Lysandro Pinto Borges Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil; Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0002-1721-1547
  • Pamela Chaves de Jesus Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0003-3282-7056
  • Jessiane Bispo de Souza Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0002-7518-6108
  • Deise Maria Rego Rodrigues Silva Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0001-8916-5271
  • Pedro Henrique Macedo Moura Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0002-5689-2090
  • Ronaldy Santana Santos Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0002-4928-7802
  • Marina dos Santos Barreto Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0003-4724-0688
  • Adriana Gibara Guimarães Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil https://orcid.org/0000-0003-1643-5642
  • Lucas Alves da Mota Santana Graduate Program in Dentistry, Health and Biological Sciences Center, Federal University of Sergipe, Aracaju 49060-102, SE, Brazil https://orcid.org/0000-0002-8261-1504
  • Otavio Cabral-Marques Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil; DO'R Institute for Research, São Paulo, Brazil; Department of Medicine, Division of Molecular Medicine, Laboratory of Medical Investigation 29, University of São Paulo (USP) School of Medicine, São Paulo, Brazil; Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, SP, Brazil; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil https://orcid.org/0000-0002-3183-6236
  • Eloia Emanuelly Dias Silva Department of Biological Sciences, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil; Tel: +5579996396324; E-mail: eloiaemanuelly@gmail.com https://orcid.org/0000-0003-2895-4191

DOI:

https://doi.org/10.17179/excli2024-7036

Keywords:

Diabetes Mellitus, gut microbiota, insulin resistance, dysbiosis

Published

2024-04-30

How to Cite

Borges, L. P., Jesus, P. C. de, Souza, J. B. de, Silva, D. M. R. R., Moura, P. H. M., Santos, R. S., … Silva, E. E. D. (2024). The influence of gut microbiota on the progression of Type 2 Diabetes: a new perspective for treatment and prevention. EXCLI Journal, 23, 629–630. https://doi.org/10.17179/excli2024-7036

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)